Keyphrases
Lung Adenocarcinoma
100%
Epidermal Growth Factor Receptor
100%
Anaplastic Lymphoma Kinase
100%
EGFR mutation
100%
Anaplastic Lymphoma Kinase Rearrangement
100%
Multifocal Lesions
100%
EML4
100%
Advanced Lung Adenocarcinoma
77%
Co-alterations
66%
Intratumoral Heterogeneity
33%
Unifocal
33%
Pathologic Characteristics
22%
Molecular Diagnostics
22%
Genetic Characteristics
22%
Lung Cancer
11%
Treatment Strategy
11%
Immunohistochemistry
11%
Resection
11%
Primary Lesion
11%
Metastatic Lesions
11%
Relative Abundance
11%
Fluorescence in Situ Hybridization
11%
Adenocarcinoma
11%
Molecular Profiling
11%
Appropriate Treatment
11%
Molecular Subtypes
11%
Next-generation Sequencing
11%
Molecular Patterns
11%
Pulmonary Metastasis
11%
Morphological Patterns
11%
Synchronous Double Cancer
11%
Radiographic Testing
11%
Synchronous Lesions
11%
ARMS-PCR
11%
Clonal Evolution Analysis
11%
Medicine and Dentistry
Lung Adenocarcinoma
100%
Epidermal Growth Factor Receptor
100%
Anaplastic Lymphoma Kinase
100%
Prevalence
14%
Genetic Trait
14%
Primary Tumor
7%
Adenocarcinoma
7%
Lung Cancer
7%
Surgery
7%
Immunohistochemistry
7%
Metastatic Carcinoma
7%
Morphology
7%
Next Generation Sequencing
7%
Molecular Profiling
7%
Fluorescence in Situ Hybridization
7%
Polymerase Chain Reaction
7%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Anaplastic Lymphoma Kinase
100%
EML4
100%
Prevalence
14%
Genetic Trait
14%
Fluorescence in Situ Hybridization
7%
Next Generation Sequencing
7%
Morphology
7%
Clonal Evolution
7%
Polymerase Chain Reaction
7%
Immunology and Microbiology
Epidermal Growth Factor
100%
Anaplastic Lymphoma Kinase
100%
Prevalence
14%
Genetic Trait
14%
Morphology
7%
Fluorescence in Situ Hybridization
7%
Next Generation Sequencing
7%
Clonal Evolution
7%
Polymerase Chain Reaction
7%